Our research is focused at exploring the role of the innate and adaptive immunity in the pathogenesis of non-ischemic heart failure with main interest in inflammatory cardiomyopathy and heart failure with preserved ejection fraction. The relevance of extra-cardiac versus cardiac inflammation on the pathogenesis of heart failure is investigated. In addition, our research is directed at the search for novel therapeutic targets as well as the evaluation of repurposed anti-inflammatory and immunomodulatory strategies.

Kontakt Van Linthout

Prof. Dr. Dipl. Ing. Sophie Van Linthout
(PhD, FHFA, FESC)

E-mail:
Sophie.van-linthout[at]bih-charite.de
Address:
Berlin Institute of Health Center for Regenerative Therapies
Föhrer Straße 15
13353 Berlin

HFA

HFA Executive Board member
Coordinator of the Basic Science section

Nucleus Member

ESC

Nucleus Member

Chair-elect of the German Society of Cardiology WG on Myocardial Function and Energetics

DGK

Chair-elect of the German Society of Cardiology
WG on Myocardial Function and Energetics

Focus

In view of translational research, patient materials of specific heart failure cohorts are analyzed and identified targets and therapies evaluated in experimental models.

Focus

  • NLRP3 inflammasome and S100A8/A9 alarmins
  • (cardiac) fibroblasts as inflammatory supporter cells
  • cardiosplenic axis
  • interorgan interaction 
  • mechanosensitive pathways
  • cancer therapy-related cardiotoxicity
  • immunomodulating strategies: pharmacological and cell-based

Publications

Van Linthout S - Search Results - PubMed (nih.gov)

Team

Team